Shanghai - Delayed Quote CNY

Jointown Pharmaceutical Group Co., Ltd (600998.SS)

5.22 +0.07 (+1.36%)

At close: October 30 at 3:00:00 PM GMT+8

Chart Range Bar

Loading chart for 600998.SS

Previous Close 5.15
Open 5.15
Bid 5.21 x --
Ask 5.22 x --
Day's Range 5.10 - 5.27
52 Week Range 4.48 - 5.84
Volume 57,544,066
Avg. Volume 37,184,521
Market Cap (intraday) 26.322B
Beta (5Y Monthly) 0.12
PE Ratio (TTM) 13.74
EPS (TTM) 0.38
Earnings Date --
Forward Dividend & Yield 0.20 (3.83%)
Ex-Dividend Date Jun 8, 2026
1y Target Est 5.76

Jointown Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the digital pharmaceutical distribution and supply chain business in China. It operates through Distribution, Industrial, Retail, Medical and Health, and Other divisions. The company offers distribution, warehousing, medical and pharmaceutical logistics, and other services to pharmaceutical manufacturers; medicines and health products; medical, health, and technology value-added services; and digital logistics technology and supply chain solutions. It is also involved in the operation and franchising of retail pharmacy networks; general agency brand promotion business; pharmaceutical OEM business; and wholesale of medical devices. Jointown Pharmaceutical Group Co., Ltd was founded in 1999 and is headquartered in Wuhan, China.

www.jointown.com

29,862

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Distribution

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600998.SS

6.23%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

600998.SS

7.06%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

600998.SS

16.16%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

600998.SS

3.76%

SSE Composite Index (000001.SS)

1.46%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q3 FY26

Revenue 42.17B

Earnings 481.61M

Profit Margin 1.14%

FY25

FY26

10B

20B

30B

40B

0.8%

1.0%

1.2%

1.4%

1.6%

Analyst Price Targets

3.50 Low

5.76 Average

5.22 Current

6.84 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

1.14%
Return on Assets (ttm)

1.93%
Return on Equity (ttm)

5.68%
Revenue (ttm)

171.51B
Net Income Avi to Common (ttm)

1.96B
Diluted EPS (ttm)

0.38

Balance Sheet and Cash Flow

Total Cash (mrq)

22.94B
Total Debt/Equity (mrq)

46.76%
Levered Free Cash Flow (ttm)

2.37B

601607.SS Shanghai Pharmaceuticals Holding Co., Ltd

16.52 +0.55%

600886.SS SDIC Power Holdings Co., Ltd

16.13 -0.68%

601117.SS China National Chemical Engineering Co., Ltd

7.11 +3.04%

600867.SS Tonghua Dongbao Pharmaceutical Co., Ltd.

7.89 +1.41%

601098.SS China South Publishing & Media Group Co., Ltd

11.19 +1.82%

U.S. markets closed

Jointown Pharmaceutical Group Co., Ltd (600998.SS)

6.75%

3.37%

0.97%

1.95%

2.76%

-19.88%

-40.33%

Jointown Pharmaceutical Group Co., Ltd Overview Medical Distribution / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch